E. Schott
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
- Hepatology 30
- Hepatitis C virus research 19
- Hepatocellular Carcinoma Treatment and Prognosis 11
- Liver Diseases and Immunity 3
- Epidemiology 16
- Liver Disease Diagnosis and Treatment 9
- Hepatitis B Virus Studies 7
- Co-authors
- Bruno Sangro (5 shared papers)Olivier Rosmorduc (4 shared papers)Ann‐Lii Cheng (2 shared papers)Philippe Merle (2 shared papers)Kwang‐Hyub Han (2 shared papers)Julien Edeline (2 shared papers)Philippe Mathurin (2 shared papers)Robin Kate Kelley (2 shared papers)
- Journals
- Journal of Hepatology (18 papers)Annals of Oncology (4 papers)Journal of Viral Hepatitis (2 papers)Journal of Clinical Oncology (1 paper)Transplantation (1 paper)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
E. Schott
33 papers receiving 743 citations
E. Schott's Hit Papers
Peers
Comparison fields: 5 of 53
- Hepatology 558
- Oncology 328
- Pathology and Forensic Medicine 160
- Immunology 148
- Epidemiology 232
Countries citing papers authored by E. Schott
This map shows the geographic impact of E. Schott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Schott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Schott more than expected).
Fields of papers citing papers by E. Schott
This network shows the impact of papers produced by E. Schott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Schott. The network helps show where E. Schott may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Schott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC) Hit paper breakdown → | 2019 | 497 |
| 2 | 2007 | 65 | |
| 3 | 2020 | 42 | |
| 4 | 2018 | 32 | |
| 5 | 2011 | 17 | |
| 6 | 2011 | 13 | |
| 7 | 2018 | 9 | |
| 8 | 2015 | 9 | |
| 9 | 2011 | 8 | |
| 10 | 2016 | 6 | |
| 11 | 2014 | 6 | |
| 12 | Isatoribine, a toll-like receptor 7 agonist, significantly reduced plasma viral load in a clinical proof-of-concept study in patients with chronic hepatitis C virus infection. | 2004 | 5 |
| 13 | 2008 | 5 | |
| 14 | 2013 | 4 | |
| 15 | 2017 | 4 | |
| 16 | 2016 | 4 | |
| 17 | 2011 | 4 | |
| 18 | 2005 | 3 | |
| 19 | 2016 | 3 | |
| 20 | 2015 | 2 |
About E. Schott
E. Schott is a scholar working on Hepatology, Epidemiology, Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 36 papers that have together received 753 indexed citations. Recurring topics across this work include Hepatitis C virus research (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Liver Disease Diagnosis and Treatment (9 papers), Hepatitis B Virus Studies (7 papers), Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Liver Diseases and Immunity (3 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Hepatology (558 citations), Oncology (328 citations), Pathology and Forensic Medicine (160 citations), Immunology (148 citations) and Epidemiology (232 citations). E. Schott has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Bruno Sangro, Olivier Rosmorduc, Ann‐Lii Cheng, Philippe Merle, Kwang‐Hyub Han, Julien Edeline, Philippe Mathurin, Robin Kate Kelley, Thomas Yau and Jaclyn Neely. Their work appears in journals such as Journal of Hepatology, Annals of Oncology, Journal of Viral Hepatitis, Journal of Clinical Oncology and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.